Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
Amelie Burghardt
Frank van Buuren
Zisis Dimitriadis
Tim Grübbel
Hubert Seggewiss
Smita Scholtz
Dieter Horstkotte
Lothar Faber
机构：
[1] Ruhr-Universität Bochum,Clinic for Cardiology, Herz
[2] Leopoldina Hospital, und Diabeteszentrum NRW
来源：
Clinical Research in Cardiology | 2018年 / 107卷
关键词：
Hypertrophic obstructive cardiomyopathy; HOCM; ICD; Left ventricular outflow tract gradient; Percutaneous septal ablation; Sudden cardiac death;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：479 / 486
页数：7
相关论文
共 50 条
  • [1] Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Burghardt, Amelie
    van Buuren, Frank
    Dimitriadis, Zisis
    Gruebbel, Tim
    Seggewiss, Hubert
    Scholtz, Smita
    Horstkotte, Dieter
    Faber, Lothar
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (06) : 479 - 486
  • [2] Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Faber, Lothar
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2006, 11 (10) : 423 - 431
  • [3] Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Kimmelstiel, CD
    Maron, BJ
    CIRCULATION, 2004, 109 (04) : 452 - 456
  • [4] Long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Faber, L.
    Welge, D.
    Seggewiss, H.
    Hering, D.
    Oldenburg, O.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2009, 30 : 183 - 183
  • [5] LONG-TERM OUTCOME OF PERCUTANEOUS SEPTAL ABLATION FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Faber, Lothar
    Prinz, Christian
    Schumann, Martina
    Burghardt, Amelie
    Seggewiss, Hubert
    Horstkotte, Dieter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1228 - E1228
  • [6] Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    Faber, L
    Gleichmann, U
    THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (02): : 94 - 100
  • [7] Long-term outcome of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy
    Faber, L.
    Prinz, C.
    Burghardt, A.
    Seggewiss, H.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2014, 35 : 925 - 925
  • [8] Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy
    Jiang, TY
    Wu, XS
    Jia, CQ
    Zhang, Y
    Lü, Q
    CHINESE MEDICAL JOURNAL, 2002, 115 (01) : 26 - 30
  • [9] LONG-TERM OUTCOME OF PERCUTANEOUS SEPTAL ABLATION FOR SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Faber, Lothar
    Welge, Dirk
    Seggewiss, Hubert
    Hering, Detlef
    Oldenburg, Olaf
    Horstkotte, Dieter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [10] Alcohol Septal Ablation for Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy
    Messenger J.C.
    Salcedo E.E.
    Current Cardiovascular Risk Reports, 2017, 11 (5)
12345